Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease

dc.contributor.authorRumman, Amir
dc.contributor.authorCandia, Roberto
dc.contributor.authorSam, Justina J.
dc.contributor.authorCroitoru, Kenneth
dc.contributor.authorSilverberg, Mark S.
dc.contributor.authorSteinhart, A. Hillary
dc.contributor.authorNguyen, Geoffrey C.
dc.date.accessioned2020-06-30T21:23:30Z
dc.date.available2020-06-30T21:23:30Z
dc.date.issued2017
dc.format.extent8 páginas
dc.fuente.origenConveris
dc.identifier.doi10.1155/2017/7365937
dc.identifier.issn2291-2789
dc.identifier.issn2291-2797
dc.identifier.urihttps://doi.org/10.1155/2017/7365937
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/30392
dc.identifier.wosidWOS:000394088000001
dc.issue.numeroNo. 7365937
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final8
dc.pagina.inicio1
dc.revistaCanadian Journal of Gastroenterology and Hepatologyes_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.subject.otherEnfermedades inflamatorias del intestino - Terapiaes_ES
dc.subject.otherNecrosises_ES
dc.titlePublic versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Diseasees_ES
dc.typeartículo
dc.volumenVol. 2017
sipa.codpersvinculados16705
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
467 Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format
Description: